Publikationen
Sortiert nach Jahrgang:
2024
2023
2022
- Jansen, V., Gostian, A. O., Allner, M., Balk, M., Rupp, R., Iro, H., Hecht, M. & Gostian, M. (2024). Postoperative pain after parotid surgery-comparison between superficial/total parotidectomy and extracapsular dissection: a prospective observational study. Eur. Arch. Otorhinolaryngol. 2024 Oct 3.
- Zhou, J. G., Yang, J., Wang, H., Wong, A. H., Tan, F., Chen, X., He, S. S., Shen, G., Wang, Y. J., Frey, B., Fietkau, R., Hecht, M., Zhong, W., Ma, H., Gaipl, U. (2024). Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy. BMJ Oncol., 2024 Feb 1;3(1):e000128. doi: 10.1136/bmjonc-2023-000128. PMID: 39886130; PMCID: PMC11203083.
- Gostian, M., Allner, M., Rak, A., Balk, M., Rupp, R., Ostgathe, C., Mantsopoulos, K., Sievert, M., Iro, H., Hecht, M. & Gostian, A. O. (2024). Symptom Burden and Quality of Life in Long-Term Survivors with Head and Neck Cancer. Ear Nose Throat J. 2024 Dec 9:1455613241276776.
- Malygina, H., Auerbach, H., Nuesken, F., Palm, J., Hecht, M. & Dzierma, Y. (2024). Full bladder, empty rectum? Revisiting a paradigm in the era of adaptive radiotherapy. Strahlenther. Onkol. 2024 Oct 29
- Freyter, B. M., Abd Al-Razaq, M. A., Hecht, M., Rübe, C. & Rübe, C. E. (2024). Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation. Genes (Basel). 2024 Jun 27;15(7):851
- Rübe, C. E., Freyter, B. M., Tewary, G., Roemer, K., Hecht, M. & Rübe C. (2024). Radiation Dermatitis: Radiation-Induced Effects on the Structural and Immunological Barrier Function of the Epidermis. Int. J. Mol. Sci., 25(6):3320. doi: 10.3390/ijms25063320. PMID: 38542294; PMCID: PMC10970573.
- Donaubauer, A. J., Frey, B., Weber, M., Allner, M., Vogl, C., Almajali, O., Kuczera, L., Tamse, H., Balk, M., Müller, S., Eckstein, M., Zülch, L., Mogge, L., Weissmann, T., Fietkau, R., Kesting, M., Iro, H., Gaipl, U. S., Hecht, M. & Gostian, A. O. (2024). Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood. Front. Oncol., 2024 Sep 13;14:1451035
- Gkika, E., Dejonckheere, C. S., Sahlmann, J., Barth, S. A., Schimek-Jasch, T., Adebahr, S., Hecht, M., Miederer, M., Brose, A., Binder, H., König, J., Grosu, A. L., Nestle, U. & Rimner, A. (2024). Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial. Radiother. Oncol., 2024 Nov:200:110521
- Hecht, M., Frey, B., Gaipl, U. S., Tianyu, X., Eckstein, M., Donaubauer, A. J., Klautke, G., Illmer, T., Fleischmann, M., Laban, S., Hautmann, M. G., Tamaskovics, B., Brunner, T. B., Becker, I., Zhou, J. G., Hartmann, A., Fietkau, R., Iro, H., Döllinger, M., Gostian, A. O. & Kist, A. M. (2024). Machine learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial. Neoplasia. 2024 Mar:49:100953.
- Wang, S., Xiong, Y., Zhang, Y., Wang, H., Chen, M., Li, J., Luo, P., Luo, Y. H., Hecht, M., Frey, B., Gaipl, U., Li, X., Zhao, Q., Ma, H., Zhou, J. G. (2024). TCCIA: A Comprehensive Resource for Exploring CircRNA in Cancer Immunotherapy. J. Immunother. Cancer, 2024 Jan 11;12(1):e008040
- Gies, S., Melchior, P., Stroeder, R., Tänzer, T., Theobald, L., Pohlers, M., Glombitza, B., Sester, M., Solomayer, E. F. & Walch-Rückheim, B. (2024). Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse. Int J Cancer, 154(2):343-358. doi: 10.1002/ijc.34745. Epub 2023 Oct 3.PMID: 37786948
- Meier, C.M., Furtwängler, R., Welter, N., Mergen, M., Wagenpfeil, S., von Schweinitz, D., Stein, R., Kager, L., Schenk, J. P., Vokuhl, C., Kroiss-Benninger, S., Melchior, P., Warmann, S. W., Fuchs, J. & Graf, N. (2024). Can Lymph Node Involvement in Unilateral Wilms Tumor be Predicted by Preoperatively known Data in Combination with Intraoperative Findings? Ann Surg., Online ahead of print. doi: 10.1097/SLA.0000000000006393. PMID: 38864214
- Mergen, M., Welter, N., Furtwängler, R., Melchior, P., Vokuhl, C., Gessler, M., Meier, C. M., Kager, L., Schenk, J. P. & Graf, N. (2024). The impact of the route to diagnosis in nephroblastoma. Cancer Med., 10, e7226. doi: 10.1002/cam4.7226
- Welter, N., Metternich, G., Furtwängler, R., Bayoumi, A., Mergen, M., Kager, L., Vokuhl, C., Warmann, S. W., Fuchs, J., Meier, C. M., Melchior, P., Gessler, M., Wagenpfeil, S., Schenk, J. P. & Graf, N. (2024). How to improve initial diagnostic accuracy of kidney tumours in childhood without histology? Int. J. Cancer., doi: 10.1002/ijc.34870
- Fincke V. E., Steinbügl M., Chun H. E., Nemes K., Mucha M., Loßner M., Dorn F., Gastberger K., Bühner S., Sill M., Kröncke T., Siebert R., Melchior P., Furtwängler R., Schlesner M., Vokuhl C., Röcken C., Johann P. D. & Frühwald M. C. (2024). Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors. Clin. Cancer Res., 30(20): 4667-4680. doi: 10.1158/1078-0432.CCR-23-3489.
- Brunkhorst, H., Schnellhardt, S., Buttner-Herold, M., Daniel, C., Fietkau, R. & Distel, L. V. (2024). Neutrophils in HNSCC Can Be Associated with Both a Worse or Favorable Prognosis. Biomolecules, 14(2). doi.org/10.3390/biom14020205
- Ruhle, A., Weymann, M., Behrens, M., Marschner, S., Haderlein, M., Fabian, A., Senger, C., Dickstein, D. R., Kraft, J., von der Grun, J., Chen, E., Aquino-Michaels, T., Domschikowski, J., Bickel, A., Altay-Langguth, A., Kalinauskaite, G., Lewitzki, V., Bonomi, M., Blakaj, D. M., Jhawar, S. R., Baliga, S., Barve, R., Ferentinos, K., Zamboglou, C., Schnellhardt, S., Haehl, E., Spohn, S. K. B., Kuhnt, T., Zoller, D., Guckenberger, M., Budach, V., Belka, C., Bakst, R., Mayer, A., Schmidberger, H., Grosu, A. L., Balermpas, P., Stromberger, C., & Nicolay, N. H. (2024). A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation. Int. J. Radiat. Oncol. Biol. Phys., 118(5), 1282-1293. doi.org/10.1016/j.ijrobp.2023.10.025
- Schmidt, E., Distel, L., Erber, R., Buttner-Herold, M., Rosahl, M. C., Ott, O. J., Strnad, V., Hack, C. C., Hartmann, A., Hecht, M., Fietkau, R., & Schnellhardt, S. (2024). Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment. Cancers, 16(18), doi.org/10.3390/cancers16183160
- Schnellhardt, S., & Hecht, M. (2024). Strahlentherapie und molekular zielgerichtete Therapie – alles gezielt? Die Onkologie, 30(10), 938-944. doi.org/10.1007/s00761-024-01528-9
- Schnellhardt, S., Tribius, S., Linxweiler, M., Gostian, A. O., & Hecht, M. (2024). Highlights of the 2024 ASCO Annual Meeting: radiotherapy of head and neck cancer. HNO, 72(12), 862-867. doi.org/10.1007/s00106-024-01527-7
- Tewary, G., Freyter, B., Abd Al-razaq, M., Auerbach, H., Laschke, M. W., Kübelbeck, T., Kolb, A., Mangelinck, A., Mann, C., Kramer, D. & Rübe, C. E. (2024). Immunomodulatory Effects of Histone Variant H2A.J in Ionizing Radiation Dermatitis. International Journal of Radiation Oncology*Biology*Physics, Volume 118, Issue 3, Pages 801-816. doi.org/10.1016/j.ijrobp.2023.09.022
- Niewald, M., Moumeniahangar, S., Müller, L.N., Hauptmann, M. G., Dzierma, Y., Fleckenstein, J., Gräber, S., Rübe, C., Hecht, M. & Melchior, P. (2024). ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis—final results after 12-month follow-up. Strahlenther. Onkol., 200, 134–142. doi.org/10.1007/s00066-023-02152-z
- Altergot, A., Schürmann, M., Jungert, T., Auerbach, H., Nüsken, F., Palm, J., Rübe, C., Rübe, C.E. & Dzierma, Y. (2024). Imaging doses for different CBCT protocols on the Halcyon 3.0 linear accelerator – TLD measurements in an anthropomorphic phantom. Zeitschrift für Medizinische Physik, Volume 34, Issue 4, 2024, Pages 580-595. doi.org/10.1016/j.zemedi.2023.03.002
- Altergot, A., Ohlmann, C., Nüsken, F., Palm, J., Hecht, M. & Dzierma, Y. (2024). Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery. Strahlenther. Onkol. 200, 815–826. doi.org/10.1007/s00066-024-02249-z
- Mestekemper AN, Pirschel W, Krieg N, Paulmann MK, Daniel C, Amann K, Coldewey SM. Reduction in Renal Heme Oxygenase-1 Is Associated with an Aggravation of Kidney Injury in Shiga Toxin-Induced Murine Hemolytic-Uremic Syndrome. Toxins (Basel). 2024 Dec 14;16(12):543. doi: 10.3390/toxins16120543. PMID: 39728801; PMCID: PMC11679022.
- Kröller S, Schober J, Krieg N, Dennhardt S, Pirschel W, Kiehntopf M, Conway EM, Coldewey SM. The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome. Toxins (Basel). 2024 Sep 20;16(9):409. doi: 10.3390/toxins16090409. PMID: 39330867; PMCID: PMC11435709.
- Thurner, L., Ziepert, M., Berdel, C., Schmidt, C., Borchmann, P., Kaddu-Mulindwa, D., Viardot, A., Witzens-Harig, M., Dierlamm, J., Haenel, M., Metzner, B., Wulf, G., Lengfelder, E., Keller, U. B., Frickhofen, N., Nickelsen, M., Gaska, T., Griesinger, F., Mahlberg, R., Marks, R., Shpilberg, O., Lindemann, H. W., Soekler, M., Fischer von Weikersthal, L., Kiehl, M., Roemer, E., Bentz, M., Krammer-Steiner, B., Trappe, R., de Nully Brown, P., Federico, M., Merli, F., Engelhard, M., Glass, B., Schmitz, N., Truemper, L., Bewarder, M., Hartmann, F., Murawski, N., Stilgenbauer, S., Rosenwald, A., Altmann, B., Schmidberger, H., Fleckenstein, J., Loeffler, M., Poeschel, V. & Held, G. (2023). Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study. Hemasphere,7(7): e904. doi: 10.1097/HS9.0000000000000904. PMID: 37427146; PMCID: PMC10325769
- Oertel, M., Berdel, C., Held, G., Herfarth, K., Schmidberger, H., Ernst, M., Lenz, G., Borchmann, P. & Eich, H. T. (2023). The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists. Strahlenther. Onkol., 199(2): 115-120. doi: 10.1007/s00066-022-02035-9. Epub 2023 Jan 4. PMID: 36598520; PMCID: PMC9877084
- Held, G., Thurner, L., Poeschel, V., Ott, G., Schmidt, C., Christofyllakis, K., Viardot, A., Borchmann, P., Engel-Riedel, W., Frickhofen, N., Nickelsen, M., Shpilberg, O., Witzens-Harig, M., Griesinger, F., Krammer-Steiner, B., Neubauer, A., de Nully Brown, P., Federico, M., Glass, B., Schmitz, N., Wulf, G., Truemper, L., Bewarder, M., Murawski, N., Stilgenbauer, S., Rosenwald, A., Altmann, B., Engelhard, M., Schmidberger, H., Fleckenstein, J., Berdel, C., Loeffler, M. & Ziepert, M. (2023). Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial. Hemasphere, 7(7): e917. doi: 10.1097/HS9.0000000000000917. PMID: 37427145; PMCID: PMC10325764
- Mohr, T. (2023). Kombination von stereotaktischer Radiotherapie mit Checkpointinhibitoren. Strahlentherapie und Onkologie, 199:1262–1264. doi.org/10.1007/s00066-023-02160-z
- Abd Al-Razaq, M. A., Isermann, A., Hecht, M. & Rübe, C. E. (2023). Automated Image Analysis of Transmission Electron Micrographs: Nanoscale Evaluation of Radiation-Induced DNA Damage in the Context of Chromatin. Cells, 12(20): 2427. doi: 10.3390/cells12202427. PMID: 37887271
- Rübe, C. E., Raid, S., Palm, J. & Rübe, C. (2023). Radiation-Induced Brain Injury: Age Dependency of Neurocognitive Dysfunction Following Radiotherapy. Cancers, 15(11): 2999. doi: 10.3390/cancers15112999. PMID: 37296960
- Auerbach, H., Dzierma, Y., Schürmann, M., Rübe, C. & Rübe, C. E. (2023). Measuring out-of-field dose to the hippocampus in common radiotherapy indications. Radiat. Oncol., 18(1): 64. doi: 10.1186/s13014-023-02242-3. PMID: 37029409
- Abd Al-Razaq, M. A., Freyter, B. M., Isermann, A., Tewary, G., Mangelinck, A., Mann, C. & Rübe, C. E. (2023). Role of Histone Variant H2A.J in Fine-Tuning Chromatin Organization for the Establishment of Ionizing Radiation-Induced Senescence. Cells, 12(6): 916. doi: 10.3390/cells12060916. PMID: 36980257
- Auerbach, H., Faus, I., Rackwitz, S., Wolny, J. A., Chumakov, A. I., Knipp, M., Walker, F. A. & Schünemann, V. (2023). Heme protonation affects iron-NO binding in the NO transport protein nitrophorin. Journal of Inorganic Biochemistry, Vol. 246, doi.org/10.1016/j.jinorgbio.2023.112281
- Linxweiler, M., Schneider, M., Körner, S., Knebel, M., Brust, L. A., Braun, F. L., Wemmert, S., Wagner, M., Hecht, M., Schick, B. & Kühn, J. P. (2023). Expression of 3q oncogene SEC62 predicts survival in head and neck squamous cell carcinoma patients treated with primary chemoradiation. Cancers, 16(1):98
- Balk, M., Rupp, R., Sievert, M., Mantsopoulos, K., Allner, M., Grundtner, P., Mueller, S. K., Eckstein, M., Iro, H., Hecht, M. & Gostian, A. O. (2023). A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease? Eur. Arch. Otorhinolaryngol., 280(12):5489-5497
- Schnellhardt, S., Linxweiler, M., Gostian, A. O. & Hecht, M. (2023). Highlights der ASCO- und ESMO‑Jahrestagungen 2022: Strahlentherapie von Kopf‑Hals‑Tumoren. HNO, 2023 Jul;71(7):446-452. German. doi: 10.1007/s00106-023-01307-9. Epub 2023 Jun 9. PMID: 37296331.
- Schnellhardt, S., Gaipl, U. S. & Hecht, M. (2023). Keine abskopalen Effekte bei Kombination von Immuntherapie und stereotaktischer Radiotherapie bei Merkel-Zell-Karzinomen. Strahlenther. Onkol., 199(5):522-524. German. doi: 10.1007/s00066-023-02078-6. Epub 2023 Apr 12. PMID: 37042974; PMCID: PMC10133047
- Dörrich, M., Hecht, M., Fietkau, R., Hartmann, A., Iro, H., Gostian, A. O., Eckstein, M. & Kist, A. M. (2023). Explainable Convolutional Neural Networks for Assessing Head and Neck Cancer Histopathology. Diagn. Pathol., 18(1):121
- Grottker, F., Gehre, S., Reichardt, C. M., Sengedorj, A., Jost, T., Rieckmann, T., Hecht, M., Gostian, A. O., Frey, B., Fietkau, R., Gaipl, U. S. & Rückert, M. (2023). Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. Neoplasia, 45:100944
- Roesch, J., Oertel, M., Wegen, S., Trommer, M., Schleifenbaum, J., Hering, D., Mäurer, M., Knippen, S., Dobiasch, S., Waltenberger, M., von der Grün, J., Medenwald, D., Süß, C., Hoeck, M., Käsmann, L., Fleischmann, D. F., Rühle, A., Nicolay, N. H., Fabian, A., Löser, A., Heß, S., Tamaskovics, B., Vinsensia, M. & Hecht, M. (2023). Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis. Radiother. Oncol., 181:109380
- Roesch J, Rühle A, Nicolay NH, Hecht M; Young DEGRO trialists working group. Reply to the comment on "Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis'' by Kahvecioglu et al. Radiother Oncol. 2023 Nov;188:109866. doi: 10.1016/j.radonc.2023.109866. Epub 2023 Aug 22. PMID: 37619658.
- Weissmann, T., Huang, Y., Fischer, S., Roesch, J., Mansoorian, S., Ayala Gaona, H., Gostian, A. O., Hecht, M., Lettmaier, S., Deloch, L., Frey, B., Gaipl, U. S., Distel, L. V., Maier, A., Iro, H., Semrau, S., Bert, C., Fietkau, R. & Putz, F. (2023). Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracy. Front. Oncol., 13:1115258
- Weissmann, T., Rückert, M., Putz, F., Donaubauer, A. J., Hecht, M., Schnellhardt, S., Schubert, P., Roesch, J., Höfler, D., Ott, O. J., Haderlein, M., Lettmaier, S., Fietkau, R., Frey, B., Gaipl, U. S., Deloch, L. (2023). Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies. Strahlenther. Onkol., 199(12):1164-1172. doi: 10.1007/s00066-022-02038-6. Epub 2023 Jan 5. PMID: 36602569; PMCID: PMC10674008.
- Zhou, J. G., Liang, R., Wang, H. T., Jin, S.H., Hu, W., Frey, B., Fietkau, R., Hecht, M., Ma, H. & Gaipl, U. S. (2023). Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients –Knowledge from two independent international studies. Neoplasia, 37:100877
- Scheper, J., Hildebrand, L. S., Faulhaber, E. M., Deloch, L., Gaipl, U. S., Symank, J., Fietkau, R., Distel, L. V., Hecht, M. & Jost, T. (2023). Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts. Strahlenther. Onkol., 199(12):1128-1139
- Meier CM, Furtwängler R, Mergen M, Welter N, Melchior P, Schenk JP, Vokuhl C, Kager L, Kroiss-Benninger S, Wagenpfeil S, Graf N. Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy. Cancers (Basel). 2023 Feb 27;15(5):1494. doi: 10.3390/cancers15051494. PMID: 36900286; PMCID: PMC10001069.
- McAleer MF, Melchior P, Parkes J, Pater L, Rübe C, Saunders D, Paulino AC, Janssens GO, Kalapurakal J. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatr Blood Cancer. 2023 May;70 Suppl 2:e30090. doi: 10.1002/pbc.30090. Epub 2022 Dec 8. PMID: 36482883.
- Vujanić GM, Graf N, D'Hooghe E, Chowdhury T, Vokuhl C, Al-Saadi R, Pritchard-Jones K, Melchior P, Furtwängler R. Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies. Int J Cancer. 2023 Apr 15;152(8):1640-1647. doi: 10.1002/ijc.34371. Epub 2022 Nov 30. PMID: 36444500.
- Meier CM, Fuchs J, von Schweinitz D, Stein R, Wagenpfeil S, Kager L, Schenk JP, Vokuhl C, Melchior P, Welter N, Furtwängler R, Graf N. Surgical Factors Influencing Local Relapse and Outcome in the Treatment of Unilateral Nephroblastoma. Ann Surg. 2023 Aug 1;278(2):e360-e367. doi: 10.1097/SLA.0000000000005690. Epub 2022 Aug 26. PMID: 36017935.
- Zhou, J. G., Zeng, Y., Wang, H., Jin, S. H., Wang, Y. J., He, S., Frey, B., Fietkau, R., Hecht, M., Ma, H., Zhang, W., Gaipl, U. S. (2022). Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials. Ther. Adv. Med. Oncol. 2022 Sep 24;14: 17588359221126154
- Beck, M., Semrau, S., Haderlein, M., Gostian, A. O., Hartwich, J., Müller, S., Kallies, A., Geppert, C. I., Schonath, M., Putz, F., Gaipl, U., Frey, B., Saake, M., Iro, H., Uder, M., Hartmann, A., Kuwert, T., Fietkau, R., Eckstein, M., Hecht, M. (2022). Differences and similarities in the pattern of early metabolic and morphologic response after induction chemo-immunotherapy versus induction chemotherapy alone in locally advanced squamous cell head and neck cancer. Cancers (Basel). 2022 Sep 30;14(19):4811
- Stoll, E., Hader, M., Rückert, M., Weissmann, T., Lettmaier, S., Putz, F., Hecht, M., Fietkau, R., Rosin, A., Frey, B., Gaipl, U. S. (2022). Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells. Int. J. Hyperthermia, 39(1):796-805
- Olmos, M., Lutz, R., Büntemeyer, T. O., Glajzer, J., Nobis, C. P., Ries, J., Möst, T., Eckstein, M., Hecht, M., Gostian, A. O., Erdmann, M., Foerster, Y., Kesting, M., Weber, M. (2022). Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature. Front. Immunol., 13:970823. doi: 10.3389/fimmu.2022.970823. PMID: 36389668; PMCID: PMC9646561.
- Zhou, J. G., Wong, A. H., Wang, H., Jin, S. H., Tan, F., Chen, Y. Z., He, S. S., Shen, G., Frey, B., Fietkau, R., Hecht, M., Carr, S. R., Wang, R., Shen, B., Schrump, D. S., Ma, H., Gaipl, U. S. (2022). Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials. Front. Immunol., 13:961926. doi: 10.3389/fimmu.2022.961926. PMID: 36119066; PMCID: PMC9478919.
- Hecht, M., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Klautke, G., Laban, S., Hautmann, M. G., Brunner, T. B., Tamaskovics, B., Hinke, A., Zhou, J. G., Frey, B., Donaubauer, A. J., Becker, I., Semrau, S., Hartmann, A., Balermpas, P., Budach, W., Gaipl, U. S., Iro, H., Gostian, A. O. & Fietkau, R. (2022). Induction chemo-immunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radio-immunotherapy in locally advanced head and neck cancer. J. Immunother. Cancer, 2022 Jan;10(1):e003747
- Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F.A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, F., Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D. & Combs, S.E. (2022). Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations: An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther. Onkol. 198 1-11
- Jost, T., Schuster, B., Heinzerling, L., Weissmann, T., Fietkau, R., Distel, L. V., Hecht, M. (2022). Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients. Strahlenther. Onkol., 2022 Sep;198(9):838-848
- Beck, M., Hartwich, J., Eckstein, M., Schmidt, D., Gostian, A. O., Müller, S., Rutzner, S., Gaipl, U. S., von der Grün, J., Illmer, T., Hautmann, M. G., Klautke, G., Döscher, J., Brunner, T., Tamaskovics, B., Hartmann, A., Iro, H., Kuwert, T., Fietkau, R., Hecht, M., Semrau, S. (2022). F18-FDG PET/CT Imaging Early Predicts Pathologic Complete Response to Induction Chemoimmunotherapy of Locally Advanced Head and Neck Cancer: Preliminary Single-Center Analysis of the CheckRad-CD8 Trial. Ann. Nucl. Med. 2022 Jul;36(7):623-633
- Allner, M., Gostian, M., Balk, M., Rupp, R., Allner, C., Mantsopoulos, K., Osgathe, C., Iro, H., Hecht, M. & Gostian, A. O. (2022). Advance Directives in Patients with Head and Neck Cancer - Status Quo and Factors Influencing their Creation. BMC Palliative Care, 21, Article number: 47 (2022)
- Balk, M., Rupp, R., Mantsopoulos, K., Sievert, M., Gostian, M., Allner, M., Grundtner, P., Eckstein, M., Iro, H., Hecht, M., Gostian, A. O. (2022). Factors influencing the outcome of head and neck cancer of unknown primary (HNCUP). J. Clin. Med., 2022 May 10;11(10):2689
- Jost, T., Schultz, A. K., Frey, B., Vu, J., Fietkau, R., Distel, L. V. & Hecht, M. (2022). Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells. Neoplasia, 2022 Mar 8;27:100780
- Fitz, T., Sörgel, C., Rutzner, S., Hecht, M., Fietkau, R. & Distel LV. (2022). Baseline quality of life of physical function is highly relevant for overall survival in advanced rectal cancer. Healthcare, 2022, 10(1), 141
- Schuster, B., Hecht, M., Schmidt, M., Haderlein, M., Jost, T., Büttner-Herold, M., Weber, K., Denz, A., Grützmann, R., Hartmann, A., Geinitz, H., Fietkau, R. & Distel, L. V. (2022). Influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer.Cancers, 2022, 14(1), 148
- Balk, M., Vasconcelos Craveiro, A., Rupp, R., Allner, M., Grundtner, P., Eckstein, M., Hecht, M., Iro, H. & Gostian, A. O. (2022). The COVID-19 pandemic and its consequences for the diagnosis and therapy of head and neck malignancies. Eur. Rev. Med. Pharmacol. Sci., 2022 Jan; 26(1):284-290
- Weissmann, T., Rückert, M., Zhou, J. G., Seeling, M., Lettmaier, S., Donaubauer, A. J., Nimmerjahn, F., Ott, O. J., Hecht, M., Putz, F., Fietkau, R., Frey, B., Gaipl, U. S. & Deloch, L. (2022). Low-dose radiotherapy leads to a systemic anti-inflammatory shift in the pre-clinical K/BxN serum transfer model and reduces osteoarthritic pain in patients. Front. Immunol., 2022 Jan 3;12:777792
- Hecht, M., von der Grün, J., Semrau, S., Müller, S., Weissmann, T., Gaipl, U. S., Iro, H., Fietkau, R., Gostian, A. O. (2022). Highlights der ASCO- und ESMO-Jahrestagungen 2021 zur Strahlentherapie von Kopf-Hals-Tumoren [Highlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer. HNO, 70(4):258-264. German. doi: 10.1007/s00106-022-01150-4. Epub 2022 Mar 16. PMID: 35294576.
- Dubois, N., Nguyet, Diep, A., Ghuysen, A., Declaye, J., Donneau, A. F., Vogin, G., Fleckenstein, J., Coucke, P. & Ben Mustapha, S. (2022). Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region. BMC Med. Educ., 22 485
- Fleckenstein, J., Poettge,n C. & Reinmuth, N. (2022). Modern definitive radiochemotherapy-state of the art implementation and new consolidation strategies. Onkologie, 28 1071-1077
- Freyter, B. M., Abd Al-Razaq, M. A., Isermann, A., Dietz, A., Azimzadeh, O., Hekking, L., Gomolka, M. & Rübe, C. E. (2022). Nuclear Fragility in Radiation-Induced Senescence: Blebs and Tubes Visualized by 3D Electron Microscopy. Cells, 11 273
- Frueh, F. S., Gassert, L., Scheuer, C., Müller, A., Fries, P., Boewe, A. S., Ampofo, E., Rübe, C. E., Menger, M. D. & Laschke, M. W. (2022). Adipose tissue-derived microvascular fragments promote lymphangiogenesis in a murine lymphedema model. J. Tissue Eng., 13 20417314221109957
- Hippchen, Y., Tewary, G., Jung, D., Schmal, Z., Meessen, S., Palm, J. & Rübe, C.E. (2022). Cultured Human Foreskin as a Model System for Evaluating Ionizing Radiation-Induced Skin Injury. Int. Mol. Sci., 23 9830
- Hussein, E. I., Juhmani A. S. F., Jacob, J. H., Telfah, M. A., Abd Al-razaq, M. A., Al-Horani, F. A., Al Zoubi, M. S. & Malkawi, H. I. (2022). Effect of Various Local Anthropogenic Impacts on the Diversity of Coral Mucus-Associated Bacterial Communities. J. Mar. Sci. Eng., 10 863
- Kaddu-Mulindwa, D., Lesan, V., Berdel, C., Stilgenbauer, S., Bewarder, M., Thurner, L., Witzens-Harig, M., Viardot, A., Soekler, M., Keller, U., Truemper, L., Christofyllakis, K., Fleser, O., Bittenbring, J.T., Poeschel, V., Held, G. & Jagoda, P. (2022). Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leuk. Lymphoma, 63 326
- Knobe, S., Dzierma, Y., Wenske, M., Berdel, C., Fleckenstein, J., Melchior, P., Palm, J., Nuesken, F. G., Hunt, A., Engwer, C., Surulescu, C., Yilmaz, U., Reith, W. & Rübe, C. (2022). Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy. Z MED PHYS, 32 149
- Meier, C. M., Furtwängler, R., von Schweinitz, D., Stein, R., Welter, N., Wagenpfeil, S., Kager, L., Schenk, J. P., Vokuhl, C., Melchior, P., Fuchs, J. & Graf, N. (2022). Vena Cava Thrombus in Patients with Wilms Tumor. Cancers, 14 3924
- Nemes, K., Johann, P. D., Steinbügl, M., Gruhle, M., Bens, S., Kachanov, D., Teleshova, M., Hauser, P., Simon, T., Tippelt, S., Eberl, W., Chada, M., Lopez, V. S. M., Grigull, L., Hernáiz-Driever, P., Eyrich, M., Pears, J., Milde, T., Reinhard, H., Leipold, A., van de Wetering, M., Gil-da-Costa, M. J., Ebetsberger-Dachs, G., Kerl, K., Lemmer, A., Boztug, H., Furtwängler, R., Kordes, U., Vokuhl, C., Hasselblatt, M., Bison, B., Kröncke, T., Melchior, P., Timmermann, B., Gerss, J., Siebert, R. & Frühwald, M. C. (2022). Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population. Cancers, 14 2185
- Nemes, K., Johann, P. D., Tüchert, S., Melchior, P., Vokuhl, C., Siebert, R., Furtwängler, R., Frühwald, M. C. (2022). Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors. Cancer Manag. Res., 14 479
- Niewald, M., Müller, L.N., Hautmann, M.G., Dzierma, Y., Melchior, P., Gräber, S., Rübe, C., Fleckenstein, J. & working group “Benign diseases” of the DEGRO (German Society for Radiation Oncology) (2022). ArthroRad trial: multicentric prospective and randomized single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis depending on the dose-results after 3 months' follow-up. Strahlenther. Onkol., 198 370
- Schmal, Z. & Rübe, C.E. (2022). Region-Specific Effects of Fractionated Low-Dose Versus Single-Dose Radiation on Hippocampal Neurogenesis and Neuroinflammation. Cancers, 14 5477
- Schuermann, M., Dzierma, Y., Nuesken, F., Oertel, J., Rübe, C. & Melchior, P. (2022). Automatic Radiotherapy Planning for Glioblastoma Radiotherapy With Sparing of the Hippocampus and nTMS-Defined Motor Cortex. Front. Neurol., 12 787140
- Mueller, S. K., Haderlein, M., Lettmaier, S., Agaimy, A., Haller, F., Hecht, M., Fietkau, R., Iro, H., Mantsopoulos, K. (2022). Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. J. Clin. Med., 11(3):720. doi: 10.3390/jcm11030720. PMID: 35160172; PMCID: PMC8836387.
- Hecht, M., Fietkau, R., Gaipl, U. S. (2022). Definitive Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Tumoren in Kombination mit Immuncheckpointinhibition – neue Konzepte gefragt. Strahlenther. Onkol.,198(1):83-85. German. doi: 10.1007/s00066-021-01880-4. Epub 2021 Dec 6. PMID: 34873636; PMCID: PMC8760185.
- Freitag, V., Lettmaier, S., Semrau, S., Hecht, M., Mantsopoulos, K., Müller, S. K., Traxdorf, M., Iro, H., Agaimy, A., Fietkau, R., Haderlein, M. (2022). High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases. Eur. Arch. Otorhinolaryngol., 279(5):2553-2563. doi: 10.1007/s00405-021-07024-9. Epub 2021 Aug 26. PMID: 34436631; PMCID: PMC8986716.
- Müller, S., Haderlein, M., Traxdorf, M., Semrau, S., Agaimy, A., Lettmaier, S., Gostian, A. O., Schubart, C., Mantsopoulos, K., Schmidt, D., Wiesmueller, M., Sievert, M., Beck, M., Eckstein, M., Fietkau, R., Iro, H., Hecht, M. (2022). Tumortherapie synchroner Malignome verschiedener Organe – ein Fall für die interdisziplinäre Onkologie. Laryngorhinootologie., 101(4):327-330. German. doi: 10.1055/a-1540-7017. Epub 2021 Jul 23. PMID: 34298563.
- Sievert, M., Goncalves, M., Binder, B., Mueller, S. K., Rupp, R., Koch, M., Dürr, S., Traxdorf, M., Hecht, M., Iro, H., Gostian, A. O. (2022). Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. HNO, 70(1):44-50. German. doi: 10.1007/s00106-021-01029-w. Epub 2021 Apr 9. PMID: 33837444; PMCID: PMC8760217.
- Vogel, M., Gade, J., Timm, B., Schürmann, M., Auerbach, H., Nüsken, F., Rübe, C., Melchior, P., Dzierma, Y. (2022). Comparison of Breast Cancer Radiotherapy Techniques Regarding Secondary Cancer Risk and Normal Tissue Complication Probability - Modelling and Measurements Using a 3D-Printed Phantom. Front. Oncol., 12 892923
- Pirschel W, Mestekemper AN, Wissuwa B, Krieg N, Kröller S, Daniel C, Gunzer F, Tolosano E, Bauer M, Amann K, Heinemann SH, Coldewey SM. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice. Kidney Int. 2022 Jun;101(6):1171-1185. doi: 10.1016/j.kint.2021.12.024. Epub 2022 Jan 11. PMID: 35031328.
- Putz, F., Pirschel, W. & Fietkau, R. FSRT-Trial: erste Phase-III-Studie zum Vergleich fraktionierte stereotaktische Radiotherapie (FSRT) versus Einzeitradiochirurgie (SRS) bei Hirnmetastasen. Forum 37, 241–245 (2022). doi.org/10.1007/s12312-022-01065-9
- Dennhardt S, Pirschel W, Wissuwa B, Imhof D, Daniel C, Kielstein JT, Hennig-Pauka I, Amann K, Gunzer F, Coldewey SM. Targeting the innate repair receptor axis via erythropoietin or pyroglutamate helix B surface peptide attenuates hemolytic-uremic syndrome in mice. Front Immunol. 2022 Sep 23;13:1010882. doi: 10.3389/fimmu.2022.1010882. PMID: 36211426; PMCID: PMC9537456.